The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

This region encodes for the reverse transcriptase and protease enzymes, the targets of current antiretroviral drugs. Specific gene sequences are compared with that of a reference (wild-type ...

Drug regimens now offer more potent, less toxic and more durable choices in the treatment of HIV disease than ever before. This has led to a need to consider the convenient, sequential use of ...

Drug use and addiction have been linked to ... believed these poor outcomes resulted from people not taking the antiretroviral therapies that keep HIV in check, says Williams, a neuroscientist ...

Biktarvy is a complete treatment for HIV. This means you take the medication by itself, without other antiretroviral drugs (drugs used to treat HIV). If you have trouble swallowing tablets ...

Anti-retroviral Drugs Market size will reach USD 42.5 billion by 2032. Growing awareness and early diagnosis of HIV will accelerate industry expansion over 2024–2032 by promoting timely ...

Anemia prevalence was high in adult patients with HIV infection on HAART, with female sex, older age, and nonsuppressed viral load status identified as significant predictors.

The following is a summary of “Drug-drug interactions between antiretrovirals and hormonal contraception: An updated ...

The antiretroviral drug has been hailed as a potential game-changer in the fight against HIV, with early trials finding the treatment 100 percent effective in preventing HIV infection. With ...

Retail pharmacies to garner more attention The anti-retroviral drugs market from retail pharmacy segment will amass notable gains by 2032 due to easy accessibility and convenience for patients ...